Case Western Reserve University (CWRU) is partnering with PharmaTher to develop and commercialize ketamine for the treatment of…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Children with Rett syndrome whose disturbed breathing eased after treatment with mecasermin, a lab-made version of the growth hormone IGF-1,…
Repeated and well-structured upper body training of girls and women with Rett syndrome improves reaching and grasping ability, attention…
Huda Zoghbi, MD, the neurologist who discovered the MECP2 gene that causes most Rett syndrome cases, has been awarded the 2022…
Boys with Klinefelter syndrome, a genetic condition caused by an extra X chromosome, more frequently show Rett syndrome-like…
Taysha Gene Therapies has launched the clinical development of TSHA-102, an investigational gene therapy for Rett syndrome. The…
Activating the mGlu2 and mGlu3 receptors in the brain reversed learning deficits in a Rett syndrome mouse model, a…
Supplementing with Vitamin D rescued the altered activity of genes associated with Rett syndrome and improved behaviors in a…
Rett syndrome community members are invited to participate in a public meeting with the U.S. Food and Drug Administration…
Regulatory RNAs involved in nerve cell signaling and structure were altered in cell and mouse models of Rett syndrome,…